Federal Trade Commission v. American Screening, LLC

District Court, E.D. Missouri·Decided April 6, 2022·No. 4:20-cv-01021·Unknown

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI EASTERN DIVISION

FEDERAL TRADE COMMISSION, ) ) Plaintiff, ) ) v. ) No. 4:20-CV-1021 RLW ) AMERICAN SCREENING, LLC, et al., ) ) Defendants. )

MEMORANDUM AND ORDER This matter is before the Court on the Federal Trade Commission’s (“FTC”) Motion for Summary Judgment. (ECF No. 39). Defendants oppose the motion (ECF No. 52) and it is fully briefed. For the reasons below, the Court will grant the motion in part. Defendant American Screening, LLC (“American Screening”) is a Louisiana Limited Liability Company with its principal place of business in Shreveport, Louisiana. (ECF No. 50, ¶¶ 1-2). Defendant Ron Kilgarlin is the founder, Chief Executive Officer, and President of American Screening. (ECF No. 50, ¶ 4). Defendant Shawn Kilgarlin is the Quality and International Organization of Standardization (“ISO”) Manager for the company. (ECF No. 50, ¶ 5). Ron and Shawn are married. (ECF No. 50, ¶ 7). FACTS1 American Screening markets and sells medical supplies, including personal protective equipment. (“PPE”). (ECF No. 50, ¶ 9). At all relevant times herein, the company utilized a third- party fulfillment warehouse in St. Louis, Missouri. (ECF No. 50, ¶ 223). On certain occasions, customers were able to pick up orders from American Screening’s Shreveport location. (ECF No.

50, ¶ 252). Most of the company’s sales occur online. (ECF No. 50, ¶ 23). At the start of the COVID-19 pandemic, American Screening’s website stated: “All shipping occurs 24-48 hours after processing, pending product availability.” (ECF No. 50, ¶ 72). The company’s representatives reiterated this timeframe directly to some customers. (ECF No. 50, ¶ 76). In March 2020, American Screening updated its website to reflect that “[p]roducts may ship 7-10 business days after [an] order has been placed.” (ECF No. 50, ¶ 84). The company also offered overnight shipping. (ECF No. 50, ¶ 88). During at least the early part of the pandemic,2 American Screening represented to consumers that it had PPE products “in stock” and “available to ship.” (ECF No. 50, ¶ 122; ECF

No. 53, pp. 9-10). For several months in 2020, the company did not have enough PPE on hand to

1 These facts are based on FTC’s Statement of Uncontroverted Material Facts (ECF No. 50) and Defendants’ Response to FTC’s Statement of Material Facts. (ECF No. 53). Defendants also submitted a Supplemental Statement of Facts. (ECF No. 53, p. 27). Local Rule 4.01(E) states that “[e]very memorandum in opposition must be accompanied by a document titled Response to Statement of Material Facts[.]” The Rule does not contemplate a separate statement of facts by the opposing party. Even if Defendants filed their Supplemental Statement of Facts as a further response to FTC’s Statement, it is improper for two reasons: (1) It does not note the paragraph number to which it responds, as required by Rule 4.01; and (2) It contains numerous irrelevant facts pertaining to the progression of the COVID-19 pandemic. The Court will not consider Defendants’ Supplemental Statement of Facts. See Thompson v. Normandy Sch. Collaborative, No. 4:19-CV-03220-MTS, 2021 WL 3286810, at *1 (E.D. Mo. Aug. 2, 2021). 2 It is difficult to discern exact dates from the parties’ filings. satisfy demand. (ECF No. 50, ¶¶ 128-137, 146, 147; ECF No. 53, p. 11).3 American Screening itself acknowledged the shortage of PPE in various customer communications. (ECF No. 50, ¶¶ 99, 107, 139, 140, 164; ECF No. 53, pp. 12-13). The company’s inventory issues resulted in many backorders—orders the company could not immediately fulfill. (ECF No. 50, ¶¶ 165-171; ECF No. 50-22; ECF No. 50-23).4 During the

first months of the pandemic, American Screening did not inform all impacted customers that their orders would be delayed. (ECF No. 50, ¶ 180). From March to November 2020, American Screening did not know how much inventory it had and did not update all customers on the status of their orders. (ECF No. 50, ¶¶ 188-89). For at least some time during pandemic, online customers were able to order—and many did order—products that were labeled “in stock” that were not actually available. (ECF No. 50, ¶¶ 192-200).5 American Screening charged customers as soon as they hit “submit.” (ECF No. 50, ¶¶ 62-63). In these situations, American Screening could not ship products within seven to 10 business days. (ECF No. 50, ¶ 207). Ms. Bridget Lamette, the company’s Customer Service

Manager, stated during her deposition that American Screening had no way to ensure backorders

3 Defendants attempt to dispute this and many other facts with deposition testimony from LeeAnn Evans, Ms. Kilgarlin’s assistant. (ECF No. 53, p. 11). When asked whether American Screening had inventory of PPE between approximately March 2020 and October 2020, Ms. Evans stated: “I’m sure we did. I just don’t know how much. I wasn’t involved in that.” (ECF No. 50-13, p. 47). But when asked if American Screening had enough inventory to satisfy demand, Ms. Evan’s unequivocally stated: “No.” Id. This testimony does not controvert FTC’s contention that American Screening lacked sufficient inventory. It does the opposite. 4 Defendants dispute the precise number of backorders but do not dispute the existence of backorders. (ECF No. 53, p. 14). FTC’s analysis shows tens of thousands of backorders. (ECF No. 50, ¶¶ 176-178). Defendants argue that FTC’s analysis is inaccurate. (ECF No. 53, p. 14). The precise number of backorders is not essential to this analysis. It is undeniable that many customers’ orders were backordered. 5 Defendants dispute the pervasiveness of this problem but do not meaningfully dispute the fact that at some point their website advertised products as “in stock” that were not in fact in stock. (ECF No. 53, p. 16). went out on time. (ECF No. 50, ¶ 208). She also testified that it was taking “about six weeks before stuff shipped out” and that there were times when American Screening did not ship products for over 30 days. (ECF No. 50-14, pp. 93-94). Ms. Kilgarlin’s assistant, Ms. LeeAnn Evans, corroborated Ms. Lamette’s testimony about shipping times. (ECF No. 50-13, p. 106). American Screening also performed “SKU swaps” whereby it filled many orders with

brands different from those ordered by customers. (ECF No. 50, ¶ 235). In fact, for a time, the company’s website displayed brands of PPE that were no longer in stock. (ECF No. 50, ¶ 239). At his Rule 30(b)(6) deposition, Mr. William Herriage, American Screening’s Controller, testified that “many thousands” of orders were swapped without the customer’s knowledge or consent. (ECF No. 50-8, p. 115). In response to shipping delays in early 2020, American Screening did not call all affected customers to determine whether they consented to shipping delays in lieu of a refund. (ECF No. 50, ¶¶ 259-270).6 At her deposition, Ms. Evans admitted that American Screening denied refunds to customers who requested them for delayed shipments. (ECF No. 50, ¶ 292). Evans also testified

that if a customer requested a refund based on a shipping delay, the company did not process the refund but instead shipped the products. (ECF No. 50, ¶ 295). American Screening did not automatically cancel orders without a prior demand from the customer. (ECF No. 50, ¶ 310). On March 31, 2020, Mr. Kilgarlin sent an email to the company’s

6 Defendants do not meaningfully dispute this fact. While they claim that “[o]ne hundred percent of customers on American Screening’s open orders list were eventually contacted,” (ECF No. 53, p. 18), they do not state that the “open orders list” included all affected customers or that all these customers were given the option to choose between a delay or a refund. Their cited deposition testimony also fails to controvert this fact.

Free access — add to your briefcase to read the full text and ask questions with AI

Federal Trade Commission v. American Screening, LLC, (E.D. Mo. 2022).

Federal Trade Commission v. American Screening, LLC (Federal Trade Commission v. American Screening, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. W. T. Grant Co.
345 U.S. 629 (Supreme Court, 1953)
Baxter v. Palmigiano
425 U.S. 308 (Supreme Court, 1976)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Torgerson v. City of Rochester
643 F.3d 1031 (Eighth Circuit, 2011)
Kraft, Inc. v. Federal Trade Commission
970 F.2d 311 (Seventh Circuit, 1992)
Reeves v. Sanderson Plumbing Products, Inc.
530 U.S. 133 (Supreme Court, 2000)
Federal Trade Commission v. National Urological Group, Inc.
645 F. Supp. 2d 1167 (N.D. Georgia, 2008)
Federal Trade Commission v. Kitco of Nevada, Inc.
612 F. Supp. 1282 (D. Minnesota, 1985)
Federal Trade Commission v. Five-Star Auto Club, Inc.
97 F. Supp. 2d 502 (S.D. New York, 2000)
Larry Ball v. City of Lincoln
870 F.3d 722 (Eighth Circuit, 2017)
Marion Carter v. Pulaski CO Special School Dist
956 F.3d 1055 (Eighth Circuit, 2020)
Federal Trade Commission v. Payday Financial LLC
989 F. Supp. 2d 799 (D. South Dakota, 2013)